MGCD-265
- 发布日期： 2019-08-15
- 更新日期： 2025-12-16
产品详请
| 产地 |
USA
|
| 品牌 |
Targetmol
|
| 货号 |
T6351
|
| 用途 |
对照品
|
| 包装规格 |
1mg
|
| 纯度 |
98%%
|
| CAS编号 |
875337-44-3
|
| 是否进口 |
|
MGCD-265-analog (structurally related to MGCD-265) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
